DJIA 17,340.78 -337.92 -1.91%
NASDAQ 4,690.46 -81.31 -1.70%
S&P 500 2,028.93 -28.16 -1.37%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

158.80 -0.93 (-0.58%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $158.73 -0.63%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $158.53
Previous Close $159.73
Daily Range $158.28 - $160.18
52-Week Range $108.20 - $173.14
Market Cap $120.8B
P/E Ratio 25.15
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 817,831
Average Daily Volume 3,610,640
Current FY EPS $8.59





Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales

Global cancer drug sales totaled $91 billion in 2013 and are expected to breach $100 billion in sales sooner than you think. Yet, three big pharmaceutical companies currently control about half of all cancer drug sales.

Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog

Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog

Apple, Pfizer, Yahoo earnings in focus

U.S. stocks: Futures fall as Caterpillar, 3M, durable goods line up

Earnings Scheduled For January 27, 2015

TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog

5 Big Biotech Earnings Releases To Watch This Week

IYH, AMGN, ABBV, CELG: Large Inflows Detected at ETF

These 3 Dividend Stocks Could Crush the Market in 2015

AbbVie, Amgen, and Pfizer are three dividend stocks that could crush the broader market this year. Here's why.

Will Amgen (AMGN) Keep the Earnings Streak Alive in 4Q? - Analyst Blog

See More AMGN News...

AMGN's Top Competitors

AMGN $158.80 (-0.58%)
Current stock: AMGN
GILD $105.66 (-1.35%)
Current stock: GILD
CELG $123.29 (-0.67%)
Current stock: CELG
$0.00 (0.00%)
Current stock: